Table 3.
Test–retest reliability of MOBID-2 pain scale data between baseline (week 0) and week 2, and weeks 2 and 4 by intraclass correlation coefficient (ICC2,1), standard error of measurement (SEM) and smallest detectable change (SDC), assessed in controls who received treatment as usual
| Weeks 0–2 (n = 163) |
Weeks 2–4 (n = 159) |
|||||
|---|---|---|---|---|---|---|
| ICC2.1 | SEM | SDC | ICC 2.1 | SEM | SDC | |
| 1. Hand | 0.852 | 1.1 | 1.8 | 0.889 | 0.9 | 1.4 |
| 2. Arms | 0.731 | 1.6 | 2.6 | 0.785 | 1.4 | 2.3 |
| 3. Legs | 0.820 | 1.6 | 2.6 | 0.879 | 1.2 | 1.9 |
| 4. Turn over | 0.841 | 1.3 | 2.1 | 0.827 | 1.3 | 2.1 |
| 5. Sit | 0.813 | 1.2 | 1.9 | 0.828 | 1.2 | 1.9 |
| 6. Head, mouth, neck | 0.760 | 1.1 | 1.8 | 0.729 | 1.1 | 1.8 |
| 7. Heart, lung, chest wall | 0.811 | 0.9 | 1.4 | 0.861 | 0.7 | 1.1 |
| 8. Abdomen | 0.757 | 1.1 | 1.8 | 0.815 | 0.9 | 1.4 |
| 9. Pelvis, genital organs | 0.732 | 1.6 | 2.6 | 0.855 | 1.2 | 1.9 |
| 10. Skin | 0.857 | 1.2 | 1.9 | 0.822 | 1.3 | 2.1 |
| MOBID-2 total score | 0.805 | 1.9 | 3.1 | 0.852 | 1.4 | 2.3 |